Raia Drogasil S.A. RADLY
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.66B | 8.38B | 7.97B | 7.55B | 7.03B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.66B | 8.38B | 7.97B | 7.55B | 7.03B |
| Cost of Revenue | 5.88B | 5.75B | 5.51B | 5.25B | 4.89B |
| Gross Profit | 2.78B | 2.64B | 2.46B | 2.29B | 2.15B |
| SG&A Expenses | 2.18B | 2.07B | 1.94B | 1.82B | 1.72B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 40.95M | 37.19M | 36.22M | -4.90M | -4.90M |
| Total Operating Expenses | 8.11B | 7.86B | 7.49B | 7.07B | 6.60B |
| Operating Income | 550.00M | 523.55M | 480.56M | 476.06M | 428.00M |
| Income Before Tax | 282.67M | 268.27M | 229.80M | 233.99M | 226.12M |
| Income Tax Expenses | 39.05M | 36.26M | 22.97M | 30.81M | 16.82M |
| Earnings from Continuing Operations | 243.62 | 232.02 | 206.83 | 203.18 | 209.30 |
| Earnings from Discontinued Operations | 3.86M | 20.79M | 29.51M | 31.18M | 31.18M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.66M | 1.25M | -331.10K | -521.10K | -3.16M |
| Net Income | 250.14M | 254.06M | 236.02M | 233.84M | 237.32M |
| EBIT | 550.00M | 523.55M | 480.56M | 476.06M | 428.00M |
| EBITDA | 723.61M | 688.56M | 639.91M | 628.26M | 561.70M |
| EPS Basic | 0.15 | 0.16 | 0.14 | 0.14 | 0.14 |
| Normalized Basic EPS | 0.11 | 0.10 | 0.09 | 0.09 | 0.08 |
| EPS Diluted | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 |
| Normalized Diluted EPS | 0.11 | 0.10 | 0.09 | 0.09 | 0.08 |
| Average Basic Shares Outstanding | 6.49B | 6.52B | 6.56B | 6.59B | 6.72B |
| Average Diluted Shares Outstanding | 6.59B | 6.62B | 6.65B | 6.64B | 6.77B |
| Dividend Per Share | 0.03 | 0.05 | 0.06 | 0.07 | 0.04 |
| Payout Ratio | 45.02% | 44.33% | 50.11% | 50.54% | 39.94% |